SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India board to consider second interim dividend

17 Oct 2016 Evaluate

Granules India has informed that meeting of the Board of Directors of the Company is scheduled to be held on October 25, 2016, to consider and approve the Un-audited Financial Results for the second quarter ended September 30, 2016 and the payment of second interim dividend for the FY 2016-17, if any. Insider Trading Window of Granules India will be closed from October 17, 2016 to October 27, 2016 in view of the above mentioned Board Meeting.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

654.40 3.60 (0.55%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×